SMMT
Summit Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$15.62
−3.57%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-135.9%
Return on equity
-113.8%
Return on assets
-134.5%
Return on invested capital
0.00x
Asset turnover
-$405.4M
Cash from operations
$0.86
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026